Published in Seizure on April 01, 1997
Factors affecting therapeutic compliance: A review from the patient's perspective. Ther Clin Risk Manag (2008) 3.75
Risk factors associated with the epilepsy treatment gap in Kilifi, Kenya: a cross-sectional study. Lancet Neurol (2012) 1.87
Antiepileptic drug monotherapy: the initial approach in epilepsy management. Curr Neuropharmacol (2009) 1.13
Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat (2007) 0.90
Peer support groups as an intervention to decrease epilepsy-associated stigma. Epilepsy Behav (2013) 0.89
Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharm J (2014) 0.85
A literature review to investigate the link between psychosocial characteristics and treatment adherence in cancer patients. Oncol Rev (2012) 0.81
Epilepsy in Cambodia-treatment aspects and policy implications: a population-based representative survey. PLoS One (2013) 0.79
Stigma of people with epilepsy in China: views of health professionals, teachers, employers, and community leaders. Epilepsy Behav (2011) 0.79
Treatment adherence among adolescents with epilepsy: what really matters? Epilepsy Behav (2013) 0.77
Adherence to antiepileptic drugs among diverse older Americans on Part D Medicare. Epilepsy Behav (2016) 0.77
Identification and prevention of antiepileptic drug noncompliance: the collaborative use of state-supplied pharmaceutical data. ISRN Pediatr (2014) 0.76
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulations. Drug Des Devel Ther (2009) 0.75
Physician trust and depression influence adherence to factor replacement: a single-centre cross-sectional study. Haemophilia (2016) 0.75
Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications. Patient Prefer Adherence (2016) 0.75
Difficult to swallow: patient preferences for alternative valproate pharmaceutical formulations. Patient Prefer Adherence (2009) 0.75
Evaluation of self-reported medication adherence and its associated factors among epilepsy patients in Hospital Kuala Lumpur. J Basic Clin Pharm (2016) 0.75
Burn injury in epileptic patients: an experience in a tertiary institute. Ann Burns Fire Disasters (2014) 0.75
Psychosocial aspects of epilepsy: a wider approach. BJPsych Open (2016) 0.75
TAMBIS: transparent access to multiple bioinformatics information sources. Bioinformatics (2000) 6.02
Design and use of questionnaires: a review of best practice applicable to surveys of health service staff and patients. Health Technol Assess (2001) 5.84
New antiepileptic drugs: a systematic review of their efficacy and tolerability. BMJ (1996) 4.73
In utero antiepileptic drug exposure: fetal death and malformations. Neurology (2006) 3.64
Implications of socio-cultural contexts for the ethics of clinical trials. Health Technol Assess (1997) 3.57
Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ (2011) 3.50
Visual evoked responses in the diagnosis and management of patients suspected of multiple sclerosis. Brain (1975) 3.48
The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2004) 3.41
Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet (2005) 3.38
Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry (1986) 2.98
Quality of life of people with epilepsy: a European study. Epilepsia (1997) 2.72
The misdiagnosis of epilepsy and the management of refractory epilepsy in a specialist clinic. QJM (1999) 2.52
Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2001) 2.40
Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology (2010) 2.38
Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology (2008) 2.24
An association between type 1 diabetes and idiopathic generalized epilepsy. Ann Neurol (2006) 2.15
Pseudostatus epilepticus. Q J Med (1989) 2.04
The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia (1996) 2.00
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Evaluation of measures used to assess quality of life after stroke. Stroke (2000) 1.80
Patients' experiences of injury as a result of epilepsy. Epilepsia (1997) 1.73
How easy are randomized controlled trials in epilepsy to find on Medline? The sensitivity and precision of two Medline searches. Epilepsia (1996) 1.73
The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia (1997) 1.72
Development of patient satisfaction questionnaires: I. Methodological issues. Qual Health Care (1992) 1.67
Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology (2005) 1.63
The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry (2004) 1.55
In utero exposure to levetiracetam vs valproate: development and language at 3 years of age. Neurology (2014) 1.52
Mothers' evolving relationships with doctors and nurses during the chronic childhood illness trajectory. J Adv Nurs (2001) 1.52
New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry (2001) 1.50
The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency. Clin Endocrinol (Oxf) (1996) 1.47
Controlled trial of plasma exchange in acute inflammatory polyradiculoneuropathy. Lancet (1984) 1.43
Seizures provoked by blows to the head. Epilepsia (2000) 1.40
A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology (2006) 1.39
Which drug for the adult epileptic patient: phenytoin or valproate? Br Med J (Clin Res Ed) (1985) 1.36
Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol (2003) 1.35
The stigma of epilepsy: a European perspective. Epilepsia (2000) 1.32
The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry (1991) 1.31
Psychogenic non-epileptic seizures--definition, etiology, treatment and prognostic issues: a critical review. Seizure (2009) 1.30
Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure (2009) 1.28
A cost-utility analysis of interferon beta for multiple sclerosis. Health Technol Assess (1998) 1.24
Lay carers' satisfaction with community palliative care: results of a postal survey. South Tyneside MAAG Palliative Care Study Group. Palliat Med (1999) 1.22
Reality monitoring and psychotic hallucinations. Br J Clin Psychol (1991) 1.21
Cross-cultural differences in health-related quality of life of people with epilepsy: findings from a European study. Qual Life Res (1999) 1.20
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technol Assess (2007) 1.18
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology (2012) 1.15
Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia (1993) 1.11
Treatment of multiple sclerosis with interferon beta: an appraisal of cost-effectiveness and quality of life. J Neurol Neurosurg Psychiatry (2000) 1.10
Development of patient satisfaction questionnaires: II. Collaboration in practice. Qual Health Care (1992) 1.09
A comparison of phenytoin and valproate in previously untreated adult epileptic patients. J Neurol Neurosurg Psychiatry (1982) 1.09
Exploring areas of consensus and conflict around values underpinning public involvement in health and social care research: a modified Delphi study. BMJ Open (2014) 1.09
A randomized controlled trial of a health promotion education programme for people with multiple sclerosis. Clin Rehabil (2006) 1.09
Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry (1992) 1.08
Differences between neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) (1986) 1.08
Accident experience and notification rates in people with recent seizures, epilepsy or undiagnosed episodes of loss of consciousness. QJM (1995) 1.08
Child development following in utero exposure: levetiracetam vs sodium valproate. Neurology (2011) 1.06
Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry (1992) 1.06
Failure to recognize psychogenic nonepileptic seizures may cause death. Neurology (2004) 1.06
Adverse antiepileptic drug effects in new-onset seizures: a case-control study. Neurology (2011) 1.04
The quality of life of older people with epilepsy: findings from a UK community study. Seizure (2001) 1.04
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res (2001) 1.04
Effects of temperature on calcium-sensitive fluorescent probes. Biophys J (2000) 1.04
The use of the Canadian occupational performance measure as an outcome of a pain management program. Can J Occup Ther (2001) 1.03
Quantitative magnetic resonance imaging in consecutive patients evaluated for surgical treatment of temporal lobe epilepsy. Magn Reson Imaging (2000) 1.03
Plasma concentrations of sodium valproate: their clinical value. Ann Neurol (1983) 1.02
The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res (1993) 1.02
Psychogenic non-epileptic seizures--diagnostic issues: a critical review. Clin Neurol Neurosurg (2008) 1.01
The contribution made by school milk to the nutrition of primary schoolchildren. Br J Nutr (1975) 1.01
Non-epileptic attack disorder (NEAD): a comprehensive review. Seizure (1999) 1.00
Improvement in adult-onset Rasmussen's encephalitis with long-term immunomodulatory therapy. Neurology (1999) 0.99
The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav (2008) 0.99
Unfolding of acrylodan-labeled human serum albumin probed by steady-state and time-resolved fluorescence methods. Biophys J (1998) 0.99
Carbamazepine versus valproate monotherapy for epilepsy. Cochrane Database Syst Rev (2000) 0.98
Dipyridamole and postoperative ischemic deficits in aneurysmal subarachnoid hemorrhage. J Neurosurg (1985) 0.98
Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry (1997) 0.98
School meals and the nutrition of schoolchildren. Br J Prev Soc Med (1975) 0.98
Influence of some social and environmental factors on the nutrient intake and nutritional status of schoolchildren. Br J Prev Soc Med (1975) 0.97
Measuring the impact of multiple sclerosis on psychosocial functioning: the development of a new self-efficacy scale. Clin Rehabil (2001) 0.96
Prospective evaluation of a prognostic index for intrinsic supratentorial tumours. J Neurol Neurosurg Psychiatry (1995) 0.95
Overuse of monitoring of blood concentrations of antiepileptic drugs. Br Med J (Clin Res Ed) (1987) 0.95
Quality of life in treated head and neck cancer patients: a preliminary report. Clin Otolaryngol Allied Sci (1984) 0.95
Study is needed of visual field defects associated with any long term antiepileptic drug. BMJ (1998) 0.95
The development of a seizure severity scale as an outcome measure in epilepsy. Epilepsy Res (1991) 0.95
The association of sexual and physical abuse with somatization: characteristics of patients presenting with irritable bowel syndrome and non-epileptic attack disorder. Psychol Med (1999) 0.94
Concentration-effect relationships of valproic acid. Clin Pharmacokinet (1985) 0.91
Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry (1999) 0.91
Extracranial vertebral artery dissection following tonic clonic seizure. J Neurol Neurosurg Psychiatry (1991) 0.91
Development of a novel scale to assess life fulfillment as part of the further refinement of a quality-of-life model for epilepsy. Epilepsia (1994) 0.91
A comparison of adult onset and "classical" idiopathic generalised epilepsy. J Neurol Neurosurg Psychiatry (2004) 0.91